Published :
Tables : 46
Figures : 43
Category : Healthcare
No. of Pages : 216
Report Code : HC-1288
Regenerative Medicine Market is poised to value USD 27867.84 million by 2028 end at a CAGR of 15.9% during the forecast period 2022 to 2028. A growing emphasis on stem cells and increasing research and development activities in developing nations are predicted to boost the global market growth. The emerging economies are focused on advancements in technology, which is predicted to propel market proliferation worldwide. Although, high treatment costs using regenerative medicine, strict regulations by the government and inefficiency in various operations and are projected to impede the market growth. The dermatology segment dominated the dominate with respect to the generation of revenue in 2018. This subjugation can be credited to this largest global regenerative medicine market share that includes the easy availability of grafting methods for treating skin wounds and diseases. A substantial number of Food and Drug Administration (FDA) approved products for healing wounds are available for clinical applications over the last ten years. Additionally, different advanced approaches in initial phases of development endorse tissue engineering. This includes the usage of drug delivery systems and biomaterials, which influence the replication of cells and control and stimulate the immune system. Increased complications of the process of wound healing with adverse diseases, for instance, HIV and diabetes have motivated research and development activities assisting the segment growth. Major players equipped with novel technologies provide manufacturing, management, engineering, quality control services and characterization along with other facilities for researches related to the development of therapies of regeneration and clinical trials. Therefore, with a rise in clinical trials and research and development activities of regenerative medicines, the services segment is predicted to exhibit growth at a soaring rate. Key market players included in the global regenerative medicine industry are: • Acelity Holdings, Inc. • Athersys, Inc. • Cryolife, Inc. • Integra Lifesciences Corporation • Isto Biologics • Medtronic Plc. • Organogenesis Inc. • Stryker Corporation • U.S. Stem Cell, Inc. • Zimmer Biomet Holdings, Inc. (Note: The list of the major players will be updated with the latest market scenario and trends) Regenerative Medicine Market Segmentation: By Product Type • Cell Therapy • Gene Therapy • Tissue Engineering • Small Molecule & Biologic By Material • Synthetic Material o Biodegradable Synthetic Polymer o Scaffold o Artificial Vascular Graft Material o Hydrogel Material • Biologically Derived Material o Collagen o Xenogeneic Material • Genetically Engineered Material o Deoxyribonucleic Acid Transfection Vector o Genetically Manipulated Cell o Three-Dimensional Polymer Technology o Transgenic o Fibroblast o Neural Stem Cell o Gene-Activated Matrices • Pharmaceuticals o Small Molecule o Biologic By Application • Cardiovascular • Oncology • Dermatology • Musculoskeletal • Wound Healing • Ophthalmology • Neurology • Others By Region North America Europe Asia Pacific Latin America Middle East and Africa Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants FutureWise Key Takeaways: Growth prospects SWOT analysis Key trends Key data-points affecting market growth Objectives of the Study: To provide with an exhaustive analysis on the global regenerative medicine market by product type, by material, by application and by region To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) To evaluate and forecast micro-markets and the overall market To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions Profiling of companies to evaluate their market shares, strategies, financials and core competencies Flexible Delivery Model: We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement The customization Mobility Care offered are free of charge with purchase of any license of the report You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
A growing emphasis on stem cells and increasing research and development activities in developing nations are predicted to boost the global market growth. The emerging economies are focused on advancements in technology, which is predicted to propel market proliferation worldwide. Although, high treatment costs using regenerative medicine, strict regulations by the government and inefficiency in various operations and are projected to impede the market growth.
The dermatology segment dominated the dominate with respect to the generation of revenue in 2018. This subjugation can be credited to this largest global regenerative medicine market share that includes the easy availability of grafting methods for treating skin wounds and diseases. A substantial number of Food and Drug Administration (FDA) approved products for healing wounds are available for clinical applications over the last ten years.
Additionally, different advanced approaches in initial phases of development endorse tissue engineering. This includes the usage of drug delivery systems and biomaterials, which influence the replication of cells and control and stimulate the immune system. Increased complications of the process of wound healing with adverse diseases, for instance, HIV and diabetes have motivated research and development activities assisting the segment growth.
Major players equipped with novel technologies provide manufacturing, management, engineering, quality control services and characterization along with other facilities for researches related to the development of therapies of regeneration and clinical trials. Therefore, with a rise in clinical trials and research and development activities of regenerative medicines, the services segment is predicted to exhibit growth at a soaring rate.
Key market players included in the global regenerative medicine industry are:
• Acelity Holdings, Inc. • Athersys, Inc. • Cryolife, Inc. • Integra Lifesciences Corporation • Isto Biologics • Medtronic Plc. • Organogenesis Inc. • Stryker Corporation • U.S. Stem Cell, Inc. • Zimmer Biomet Holdings, Inc. (Note: The list of the major players will be updated with the latest market scenario and trends)
Regenerative Medicine Market Segmentation:
By Product Type
• Cell Therapy • Gene Therapy • Tissue Engineering • Small Molecule & Biologic
By Material
• Synthetic Material o Biodegradable Synthetic Polymer o Scaffold o Artificial Vascular Graft Material o Hydrogel Material • Biologically Derived Material o Collagen o Xenogeneic Material • Genetically Engineered Material o Deoxyribonucleic Acid Transfection Vector o Genetically Manipulated Cell o Three-Dimensional Polymer Technology o Transgenic o Fibroblast o Neural Stem Cell o Gene-Activated Matrices • Pharmaceuticals o Small Molecule o Biologic
By Application
• Cardiovascular • Oncology • Dermatology • Musculoskeletal • Wound Healing • Ophthalmology • Neurology • Others
By Region
Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants
FutureWise Key Takeaways:
Objectives of the Study:
Flexible Delivery Model:
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Regenerative Medicine Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Regenerative Medicine Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Regenerative Medicine Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Regenerative Medicine Market, By Product Type Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Cell Therapy 7.2. Gene Therapy 7.3. Tissue Engineering 7.4. Small Molecule & Biologic 8. Regenerative Medicine Market, By Material Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Synthetic Material 8.1.1. Biodegradable Synthetic Polymer 8.1.2. Scaffold 8.1.3. Artificial Vascular Graft Material 8.1.4. Hydrogel Material 8.2. Biologically Derived Material 8.2.1. Collagen 8.2.2. Xenogeneic Material 8.3. Genetically Engineered Material 8.3.1. Deoxyribonucleic Acid Transfection Vector 8.3.2. Genetically Manipulated Cell 8.3.3. Three-Dimensional Polymer Technology 8.3.4. Transgenic 8.3.5. Fibroblast 8.3.6. Neural Stem Cell 8.3.7. Gene-Activated Matrices 8.4. Pharmaceuticals 8.4.1. Small Molecule 8.4.2. Biologic 9. Regenerative Medicine Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Cardiovascular 9.2. Oncology 9.3. Dermatology 9.4. Musculoskeletal 9.5. Wound Healing 9.6. Ophthalmology 9.7. Neurology 9.8. Others 10. North America Regenerative Medicine Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 10.2.1. U.S.A 10.2.2. Canada 10.2.3. Mexico 10.3. Market Size (USD Million) Forecast for North America 2022-2028 11. Latin America Regenerative Medicine Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. Brazil 11.2.2. Venezuela 11.2.3. Argentina 11.2.4. Rest of Latin America 11.3. Market Size (USD Million) Forecast for Latin America 2022-2028 12. Europe Regenerative Medicine Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Germany 12.2.2. U.K 12.2.3. France 12.2.4. Italy 12.2.5. Spain 12.2.6. Russia 12.2.7. Poland 12.2.8. Rest of Europe 12.3. Market Size (USD Million) Forecast for Europe 2022-2028 13. Asia Pacific Regenerative Medicine Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Japan 13.2.2. China 13.2.3. India 13.2.4. Australia and New Zealand 13.2.5. ASEAN 13.2.6. Rest of Asia Pacific 13.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028 14. Middle East and Africa Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. GCC 14.2.2. Israel 14.2.3. South Africa 14.2.4. Rest of MEA 14.3. Market Size (USD Million) Forecast for MEA 2022-2028 15. Market Share Analysis and Competitive Landscape 15.1. Global Landscape - Key Players, Revenue and Presence 15.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 15.3. Global Emerging Companies 15.4. North America - Market Share Analysis and Key Regional Players 15.5. Europe - Market Share Analysis and Key Regional Players 15.6. Asia Pacific - Market Share Analysis and Key Regional Players 15.7. Global Key Player - Growth Matrix 16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 16.1. Acelity Holdings, Inc. 16.1.1. Company Overview 16.1.2. Product Portfolio 16.1.3. SWOT Analysis 16.1.4. Financial Overview 16.1.5. Strategic Overview 16.2. Athersys, Inc. 16.2.1. Company Overview 16.2.2. Product Portfolio 16.2.3. SWOT Analysis 16.2.4. Financial Overview 16.2.5. Strategic Overview 16.3. Cryolife, Inc. 16.3.1. Company Overview 16.3.2. Product Portfolio 16.3.3. SWOT Analysis 16.3.4. Financial Overview 16.3.5. Strategic Overview 16.4. Integra Lifesciences Corporation 16.4.1. Company Overview 16.4.2. Product Portfolio 16.4.3. SWOT Analysis 16.4.4. Financial Overview 16.4.5. Strategic Overview 16.5. Isto Biologics 16.5.1. Company Overview 16.5.2. Product Portfolio 16.5.3. SWOT Analysis 16.5.4. Financial Overview 16.5.5. Strategic Overview 16.6. Medtronic Plc. 16.6.1. Company Overview 16.6.2. Product Portfolio 16.6.3. SWOT Analysis 16.6.4. Financial Overview 16.6.5. Strategic Overview 16.7. Organogenesis Inc. 16.7.1. Company Overview 16.7.2. Product Portfolio 16.7.3. SWOT Analysis 16.7.4. Financial Overview 16.7.5. Strategic Overview 16.8. Stryker Corporation 16.8.1. Company Overview 16.8.2. Product Portfolio 16.8.3. SWOT Analysis 16.8.4. Financial Overview 16.8.5. Strategic Overview 16.9. U.S. Stem Cell, Inc. 16.9.1. Company Overview 16.9.2. Product Portfolio 16.9.3. SWOT Analysis 16.9.4. Financial Overview 16.9.5. Strategic Overview 16.10.Zimmer Biomet Holdings, Inc. 16.10.1. Company Overview 16.10.2. Product Portfolio 16.10.3. SWOT Analysis 16.10.4. Financial Overview 16.10.5. Strategic Overview 17. Pre and Post COVID-19 Impact 17.1. Positive influence on the healthcare industry 17.2. The financial disruption of the manufacturing sector 17.3. Impact of COVID-19 on emerging companies 17.4. Significant mandates in the healthcare regulations initiated by Cryolife, Inc.inistrations 17.5. The overall economic slowdown of the developing and developed nations 18. FutureWise SME Key Takeaway Points for Client
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders
2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study
3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights
4. Regenerative Medicine Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances
5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Regenerative Medicine Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Regenerative Medicine Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies
7. Regenerative Medicine Market, By Product Type Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Cell Therapy 7.2. Gene Therapy 7.3. Tissue Engineering 7.4. Small Molecule & Biologic
8. Regenerative Medicine Market, By Material Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Synthetic Material 8.1.1. Biodegradable Synthetic Polymer 8.1.2. Scaffold 8.1.3. Artificial Vascular Graft Material 8.1.4. Hydrogel Material 8.2. Biologically Derived Material 8.2.1. Collagen 8.2.2. Xenogeneic Material 8.3. Genetically Engineered Material 8.3.1. Deoxyribonucleic Acid Transfection Vector 8.3.2. Genetically Manipulated Cell 8.3.3. Three-Dimensional Polymer Technology 8.3.4. Transgenic 8.3.5. Fibroblast 8.3.6. Neural Stem Cell 8.3.7. Gene-Activated Matrices 8.4. Pharmaceuticals 8.4.1. Small Molecule 8.4.2. Biologic
9. Regenerative Medicine Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Cardiovascular 9.2. Oncology 9.3. Dermatology 9.4. Musculoskeletal 9.5. Wound Healing 9.6. Ophthalmology 9.7. Neurology 9.8. Others
10. North America Regenerative Medicine Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 10.2.1. U.S.A 10.2.2. Canada 10.2.3. Mexico 10.3. Market Size (USD Million) Forecast for North America 2022-2028
11. Latin America Regenerative Medicine Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. Brazil 11.2.2. Venezuela 11.2.3. Argentina 11.2.4. Rest of Latin America 11.3. Market Size (USD Million) Forecast for Latin America 2022-2028
12. Europe Regenerative Medicine Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Germany 12.2.2. U.K 12.2.3. France 12.2.4. Italy 12.2.5. Spain 12.2.6. Russia 12.2.7. Poland 12.2.8. Rest of Europe 12.3. Market Size (USD Million) Forecast for Europe 2022-2028
13. Asia Pacific Regenerative Medicine Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Japan 13.2.2. China 13.2.3. India 13.2.4. Australia and New Zealand 13.2.5. ASEAN 13.2.6. Rest of Asia Pacific 13.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028
14. Middle East and Africa Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. GCC 14.2.2. Israel 14.2.3. South Africa 14.2.4. Rest of MEA 14.3. Market Size (USD Million) Forecast for MEA 2022-2028
15. Market Share Analysis and Competitive Landscape 15.1. Global Landscape - Key Players, Revenue and Presence 15.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 15.3. Global Emerging Companies 15.4. North America - Market Share Analysis and Key Regional Players 15.5. Europe - Market Share Analysis and Key Regional Players 15.6. Asia Pacific - Market Share Analysis and Key Regional Players 15.7. Global Key Player - Growth Matrix
16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 16.1. Acelity Holdings, Inc. 16.1.1. Company Overview 16.1.2. Product Portfolio 16.1.3. SWOT Analysis 16.1.4. Financial Overview 16.1.5. Strategic Overview 16.2. Athersys, Inc. 16.2.1. Company Overview 16.2.2. Product Portfolio 16.2.3. SWOT Analysis 16.2.4. Financial Overview 16.2.5. Strategic Overview 16.3. Cryolife, Inc. 16.3.1. Company Overview 16.3.2. Product Portfolio 16.3.3. SWOT Analysis 16.3.4. Financial Overview 16.3.5. Strategic Overview 16.4. Integra Lifesciences Corporation 16.4.1. Company Overview 16.4.2. Product Portfolio 16.4.3. SWOT Analysis 16.4.4. Financial Overview 16.4.5. Strategic Overview 16.5. Isto Biologics 16.5.1. Company Overview 16.5.2. Product Portfolio 16.5.3. SWOT Analysis 16.5.4. Financial Overview 16.5.5. Strategic Overview 16.6. Medtronic Plc. 16.6.1. Company Overview 16.6.2. Product Portfolio 16.6.3. SWOT Analysis 16.6.4. Financial Overview 16.6.5. Strategic Overview 16.7. Organogenesis Inc. 16.7.1. Company Overview 16.7.2. Product Portfolio 16.7.3. SWOT Analysis 16.7.4. Financial Overview 16.7.5. Strategic Overview 16.8. Stryker Corporation 16.8.1. Company Overview 16.8.2. Product Portfolio 16.8.3. SWOT Analysis 16.8.4. Financial Overview 16.8.5. Strategic Overview 16.9. U.S. Stem Cell, Inc. 16.9.1. Company Overview 16.9.2. Product Portfolio 16.9.3. SWOT Analysis 16.9.4. Financial Overview 16.9.5. Strategic Overview 16.10.Zimmer Biomet Holdings, Inc. 16.10.1. Company Overview 16.10.2. Product Portfolio 16.10.3. SWOT Analysis 16.10.4. Financial Overview 16.10.5. Strategic Overview
17. Pre and Post COVID-19 Impact 17.1. Positive influence on the healthcare industry 17.2. The financial disruption of the manufacturing sector 17.3. Impact of COVID-19 on emerging companies 17.4. Significant mandates in the healthcare regulations initiated by Cryolife, Inc.inistrations 17.5. The overall economic slowdown of the developing and developed nations
18. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics